TurboCHO™ Protein Expression Kit: A New Standard for Rapid, Consistent, and High‑Yield CHO Expression
TurboCHO™ Protein Expression Kit enables rapid and consistent transient protein expression in CHO cells by integrating speed, productivity, and reproducibility into a single optimized system. Built on an engineered CHO‑K1 platform, TurboCHO™ achieves high protein titers within 3–7 days post‑transfection, significantly reducing turnaround time compared with conventional transient CHO methods. Designed to align with standard CHO workflows, the system supports straightforward adoption while enabling faster candidate screening and more confident early‑stage biologics decision‑making.

Hanying Luo, Ph.D. is Director of Protein & Antibody Solutions at GenScript, where she leads product strategy and development for protein expression and antibody discovery platforms supporting biologics research and drug discovery. She received her Ph.D. in Materials Science and Engineering from Johns Hopkins University. With over eight years of experience in product management in the life sciences & Biotech industry, Dr. Luo has worked across a broad range of technologies, including chemicals, molecular biology tools, gene products, and protein expression systems. Her work focuses on developing integrated solutions that accelerate protein production and enable high-throughput biologics discovery workflows.

A Next-Generation Transient CHO Expression Platform Accelerating Antibody Discovery
Fast experimental iteration remains a key limitation in antibody discovery, especially as AI-driven and high-throughput approaches generate large candidate panels. Conventional transient CHO expression (7–10 days) can slow evaluation, particularly for complex formats. We developed an engineered CHO-K1 platform powering TurboCHO™ 3.0, delivering improved transfection efficiency and productivity with titers up to 5 g/L. The system supports diverse antibody formats, including bispecifics and multispecifics, with purity suitable for downstream assays, enabling faster and higher-throughput screening. To extend these benefits in-house, the TurboCHO™ Protein Expression Kit leverages the same platform to shorten expression timelines by ~3–7 days versus conventional CHO workflows while maintaining strong yields. Together, the TurboCHO platform enables faster protein access and more efficient decision-making across antibody discovery workflows.

Lucas Siow is a Field Application Scientist at GenScript, supporting antibody discovery and protein expression technologies across Europe. With a strong background in molecular biology and cell biology, he works closely with customers on technical evaluation, workflow optimization, and translating complex scientific needs into practical solutions.

Improving Scalable, High-Throughput Affinity Protein Purification Workflows with Magnetic Beads-Based Automated Solutions
Conventional gravity-column protein typically requires extensive manual efforts and prolonged processing times that introduces run-to-run variability, particularly when purifying multiple samples. Advances in magnetic beads technology have  since simplified and expedited the purification workflow by eliminating the need for sample clarification and offering strong compatibility with high-throughput platforms. This work presents the use of automated  magnetic bead-based platforms to perform mini and midi-scale purification  of His-tagged proteins featuring integrated cell lysis and high reproducibility.

Guillermo Fernandez Rodriguez,  Ph.D., is a Biotechnologist and Field Application Scientist at GenScript with expertise in Genetics and Molecular Biology. He supports R&D labs  in implementing automated robotic platforms for plasmid and protein  purification. With a background in molecular oncology and drug discovery,   he focuses on applying scientific rigor to translational and preclinical research challenges in therapeutic development.